COMMUNIQUÉS West-GlobeNewswire

Burning Rock Reports Second Quarter 2024 Financial Results
23/08/2024
GUANGZHOU, China, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) [...]
Brains Bioceutical s’apprête à obtenir l’une des premières certifications CEP pour le cannabidiol au monde auprès de la Direction européenne de la qualité du médicament et soins de santé
23/08/2024
Faire progresser l’innovation pharmaceutique : la certification CEP de Brains Bioceutical permettra de simplifier le développement de médicaments à base de cannabinoïdes, en s’inspirant du médicament contre l’épilepsie [...]
NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report
22/08/2024
SANTA ANA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced it received a standard notice (the “Notice”) on August 20, 2024 from the Listing [...]
Ovarian Cancer Canada announces its annual Walk of Hope to support Canadians facing ovarian cancer
22/08/2024
Join or donate to one of the 31 walks across Canada on September 8, visit www.ovariancancerwalkofhope.ca TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Held annually during Ovarian Cancer Awareness Month in September, [...]
Vision Sensing Acquisition Corp. Announces Letter of Intent with Convergence CT, Inc.
22/08/2024
Agrees to Terminate Previous Agreement with Mediforum Co., Ltd. Convergence CT, Inc. (“CCT”) is a provider of technologies to manage big data for the benefit of patients, communities, providers, and researchers, and [...]
SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024
22/08/2024
SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the [...]
Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 – Conference Call to Follow
22/08/2024
WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will announce its second quarter 2024 financial results after market close on Thursday, August 29, 2024 [...]
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
22/08/2024
DEER PARK, Ill., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2024
22/08/2024
Posters to be presented highlight clinical study designs investigating pegtibatinase as the first potential disease-modifying treatment for classical homocystinuria SAN DIEGO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Travere [...]
Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
22/08/2024
PONTE VEDRA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
BrightSpring Health Services, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
22/08/2024
LOUISVILLE, Ky., Aug. 22, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that the Company will participate in the Morgan Stanley 22 nd Annual [...]
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
22/08/2024
REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be [...]
NeuroPace to Participate in Upcoming Healthcare Conferences in September
22/08/2024
MOUNTAIN VIEW, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will participate in [...]
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
22/08/2024
ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]
Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
22/08/2024
SEATTLE, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
22/08/2024
Company announcement – No. 41 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, August 22, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR [...]
CORRECTION -- InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center
22/08/2024
PACE Program Provides Highly Coordinated Personalized Senior Care in Partnership with Eskaton and Adventist Health In a release issued under the same headline on Friday, August 16, 2024, by InnovAge, please note the [...]
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
22/08/2024
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older The KP.2 adaptation is based on FDA guidance, which stated [...]
Six-month interim report (Q2) 2024
22/08/2024
Company release No. 16/2024 ALK delivers 21% organic revenue growth with an operating profit margin of 19% in Q2 (unaudited) Revenue growth was driven by a continued strong momentum in tablet sales, and improved [...]

Pages